Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Radivoyevitch

Showing results (11-20 of 29) with videos related to

Pageof 3
Sort By:
Nucleosides, Nucleotides & Nucleic Acids|April 15, 2011
A mathematical model of human thymidine kinase 2 activityT Radivoyevitch, B Munch-Petersen, L Wang, et al.
Mathematical Biosciences|June 11, 1998
Size distributions of misrejoining DNA fragments in irradiated cellsT Radivoyevitch, D G Hoel, P Hahnfeldt, et al.
Radiation Research|January 8, 1998
Misrejoining of double-strand breaks after X irradiation: relating moderate to very high doses by a Markov modelT Radivoyevitch, D G Hoel, A M Chen, et al.
Micro Total Analysis Systems : Proceedings of the ... [Mu] TAS International Conference on Miniaturized Chemical and Biochemical Analysis Systems. [Mu] TAS (Conference)|April 24, 2010
A combinatorial multicomponent plug mixer for systems chemistryF Azizi, Q Wan, T Radivoyevitch, et al.
Radiation Research|January 8, 1998
Recent data obtained by pulsed-field gel electrophoresis suggest two types of double-strand breaksT Radivoyevitch, D G Hoel, P J Hahnfeldt, et al.
Radiation and Environmental Biophysics|January 11, 2002
On target cell numbers in radiation-induced H4-RET mediated papillary thyroid cancerT Radivoyevitch, R K Sachs, Y E Nikiforov, et al.
Leukemia|December 8, 2016
The relationship between eligibility criteria and adverse events in randomized controlled trials of hematologic malignanciesA Statler, T Radivoyevitch, C Siebenaller, et al.
Leukemia|October 14, 2015
Defining AML and MDS second cancer risk dynamics after diagnoses of first cancers treated or not with radiationT Radivoyevitch, R K Sachs, R P Gale, et al.
Leukemia|June 18, 2016
Incorporation of molecular data into the Revised International Prognostic Scoring System in treated patients with myelodysplastic syndromesA Nazha, M Narkhede, T Radivoyevitch, et al.
Leukemia|September 23, 2017
Distinct clinical and biological implications of various DNMT3A mutations in myeloid neoplasmsS K Balasubramanian, M Aly, Y Nagata, et al.
Pageof 3

Showing results (11-20 of 29) with videos related to

Sort By:
Pageof 3
Nucleosides, Nucleotides & Nucleic Acids|April 15, 2011
A mathematical model of human thymidine kinase 2 activityT Radivoyevitch, B Munch-Petersen, L Wang, et al.
Mathematical Biosciences|June 11, 1998
Size distributions of misrejoining DNA fragments in irradiated cellsT Radivoyevitch, D G Hoel, P Hahnfeldt, et al.
Radiation Research|January 8, 1998
Misrejoining of double-strand breaks after X irradiation: relating moderate to very high doses by a Markov modelT Radivoyevitch, D G Hoel, A M Chen, et al.
Micro Total Analysis Systems : Proceedings of the ... [Mu] TAS International Conference on Miniaturized Chemical and Biochemical Analysis Systems. [Mu] TAS (Conference)|April 24, 2010
A combinatorial multicomponent plug mixer for systems chemistryF Azizi, Q Wan, T Radivoyevitch, et al.
Radiation Research|January 8, 1998
Recent data obtained by pulsed-field gel electrophoresis suggest two types of double-strand breaksT Radivoyevitch, D G Hoel, P J Hahnfeldt, et al.
Radiation and Environmental Biophysics|January 11, 2002
On target cell numbers in radiation-induced H4-RET mediated papillary thyroid cancerT Radivoyevitch, R K Sachs, Y E Nikiforov, et al.
Leukemia|December 8, 2016
The relationship between eligibility criteria and adverse events in randomized controlled trials of hematologic malignanciesA Statler, T Radivoyevitch, C Siebenaller, et al.
Leukemia|October 14, 2015
Defining AML and MDS second cancer risk dynamics after diagnoses of first cancers treated or not with radiationT Radivoyevitch, R K Sachs, R P Gale, et al.
Leukemia|June 18, 2016
Incorporation of molecular data into the Revised International Prognostic Scoring System in treated patients with myelodysplastic syndromesA Nazha, M Narkhede, T Radivoyevitch, et al.
Leukemia|September 23, 2017
Distinct clinical and biological implications of various DNMT3A mutations in myeloid neoplasmsS K Balasubramanian, M Aly, Y Nagata, et al.
Pageof 3